Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Yoshimura, Satoshi ^a   Isobe, Noriko ^a   Yonekawa, Tomomi ^a   Matsushita, Takuya ^a   Masaki, Katsuhisa ^a   Sato, Shinya ^a   Kawano, Yuji ^b   Yamamoto, Ken ^c   Kira, Jun ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; HLA DPB1 ANTIGEN; HLA DRB1 ANTIGEN;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HELICOBACTER PYLORI; HLA DPB1 GENE; HLA DRB1 GENE; HUMAN; INFECTION; INFECTION RISK; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NONHUMAN; PHENOTYPIC VARIATION; RISK ASSESSMENT; RISK FACTOR; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS GENE;

ADOLESCENT; ADULT; ALLELES; ANTIBODIES; AQUAPORIN 4; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHLAMYDOPHILA PNEUMONIAE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENE FREQUENCY; GENOTYPE; HELICOBACTER PYLORI; HERPESVIRUS 3, HUMAN; HLA-DP BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHENOTYPE; YOUNG ADULT;

CHLAMYDOPHILA PNEUMONIAE; HELICOBACTER PYLORI; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4;

EID: 84869055331     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048592     Document Type: Article

References (45)

1. Kira J, (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2: 117-127.
2. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG, (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114.
3. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112.
4. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR, (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477.
5. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG, (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-15.
6. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, et al. (2007) Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130: 1206-1223.
7. Tanaka K, Tani T, Tanaka M, Saida T, Idezuka J, et al. (2007) Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 13: 850-855.
8. Matsushita T, Isobe N, Matsuoka T, Shi N, Kawano Y, et al. (2009) Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler 15: 834-847.
9. Ishizu T, Kira J, Osoegawa M, Fukazawa T, Kikuchi S, et al. (2009) Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. J Neurol Sci 280: 22-28.
10. Minohara M, Matsuoka T, Li W, Osoegawa M, Ishizu T, et al. (2006) Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol 178: 156-160.
11. Matsuoka T, Matsushita T, Osoegawa M, Ochi H, Kawano Y, et al. (2008) Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 266: 115-125.
12. Ebers GC, (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7: 268-277.
13. Osoegawa M, Kira J, Fukazawa T, Fujihara K, Kikuchi S, et al. (2009) Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 15 159-173.
14. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A, (2010) Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 67: 824-830.
15. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV, (2010) Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 6: 156-166.
16. Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, et al. (1966) Epidemiological study of multiple sclerosis in Israel. Part II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 29: 60-68.
17. Ponsonby AL, van der Mei I, Dwyer T, Blizzard L, Taylor B, et al. (2005) Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 293: 463-469.
18. Yazdanbakhsh M, Kremsner PG, van Ree R, (2002) Allergy, parasites, and the hygiene hypothesis. Science 296: 490-494.
19. Giovannoni G, Ebers G, (2007) Multiple sclerosis: the environment and causation. Curr Opin Neurol 20: 261-268.
20. Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, et al. (2007) HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One 2: e664.
21. Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, et al. (1996) Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40: 569-574.
22. Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, et al. (1999) HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122: 1689-1696.
23. Ono T, Zambenedetti MR, Yamasaki K, Kawano Y, Kamikawaji N, et al. (1998) Molecular analysis of HLA class I (HLA-A and-B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type). Tissue Antigens 52: 539-542.
24. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
25. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489.
26. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
27. Poser S, Ritter G, Bauer HJ, Grosse-Wilde H, Kuwert EK, et al. (1981) HLA-antigens and the prognosis of multiple sclerosis. J Neurol 225: 219-221.
28. Nakashima I, Fujihara K, Sato S, Itoyama Y, (2005) Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis. J Neuroimmunol 159: 133-136.
29. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059-2069.
30. Matsushita T, Matsuoka T, Isobe N, Kawano Y, Minohara M, et al. (2008) Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 73: 171-176.
31. Li W, Minohara M, Piao H, Matsushita T, Masaki K, et al. (2009) Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult Scler 15: 1411-1421.
32. Mitsunaga S, Kuwata S, Tokunaga K, Uchikawa C, Takahashi K, et al. (1992) Family study on HLA-DPB1 polymorphism: linkage analysis with HLA-DR/DQ and two "new" alleles. Hum Immunol. 34: 203-211.
33. Imrell K, Landtblom AM, Hillert J, Masterman T, (2006) Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67: 1062-1064.
34. Kikuchi S, Fukazawa T, Niino M, Yabe I, Miyagishi R, et al. (2003) HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Neurology 60: 647-651.
35. Sundström P, Nyström L, Jidell E, Hallmans G, (2008) EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Mult Scler 14: 1120-1122.
36. Wu JS, Qiu W, Castley A, James I, Joseph J, et al. (2010) Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. J Neurol Sci 288: 63-67.
37. Romero-Pinel L, Martinez-Yélamos S, Bau L, Matas E, Gubieras L, et al. (2011) Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Eur J Neurol 18: 1258-1262.
38. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, et al. (2009) Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 132: 250-259.
39. Buljevac D, van Doornum GJJ, Flach HZ, Groen J, Osterhaus ADME, et al. (2005) Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 76: 1377-1381.
40. Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, et al. (2009) Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 73: 32-38.
41. Fukazawa T, Yamasaki K, Ito H, Kikuchi S, Minohara M, et al. (2000) Both the HLA-DPB1 and-DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 55: 199-205.
42. Dekker JW, Easteal S, Jakobsen IB, Gao X, Stewart GJ, et al. (1993) HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1*0602 allele. Tissue Antigens 41: 31-36.
43. Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, et al. (2001) Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 10: 2907-2916.
44. Qiu W, James I, Carroll WM, Mastaglia FL, Kermode AG, (2010) HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis. Mult Scler 17: 382-388.
45. Fujisao S, Matsushita S, Nishi T, Nishimura Y, (1996) Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSE5 random peptide library. Human Immunol 45: 131-136.